Navigation Links
Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
Date:9/16/2009

>

About Keryx Biopharmaceuticals

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, a key signaling cascade that has been shown to induce cell growth and cell transformation. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types, with a Phase 3 in multiple myeloma, under Special Protocol Assessment (SPA), pending commencement by year-end. Keryx is also developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, and Keryx is in the process of finalizing the U.S. Phase 3 program for Zerenex in

consultation with the FDA. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical trials and business prospects for KRX-0401 (perifosine), may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in t
'/>"/>

SOURCE Keryx Biopharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
5. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
9. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
10. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
11. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... 27, 2015 , ... Interactive health education is a highly ... Wound Care Advantage beta launched Luvo University, an online learning management ... learning paths allow for clinicians, physicians, hyperbaric technicians and non-clinical staff to get ...
(Date:7/27/2015)... ... July 27, 2015 , ... Writing Effective ... Aug. 13, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/writingeffectivesops ... FDA investigators will look at during an inspection. Yet, in 2014, "inadequate ...
(Date:7/27/2015)... ... , ... In a piece published July 22 on LinkedIn’s Pulse, ... explained why people should not shy away from their own personal aspirations. The author ... and celebrate it for the modern wonder that it is.” This is a great ...
(Date:7/27/2015)... ... ... Looking to brush up on all the things you should be doing ... enhanced its Dental webpage with new materials, including user-friendly, educational videos, to help members ... to offering our 3.8 million members tools and resources to help them keep a ...
(Date:7/27/2015)... TX (PRWEB) , ... July 27, 2015 , ... North ... of 2015. , The center invites all those prospective joint-replacement patients, along with ... and Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 4Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2
... cases of bird flu, the chief state epidemiologist Gennady ... the sixth country where the deadly H5N1 bird flu virus ... outside eastern Asia. ,"I earnestly advise Russian citizens ... province of Agri and the city of Dogubayazit where the ...
... year. The need the organ, kidney is on the rise and ... all the organ transplantations done, kidney transplantation accounts for 64%. But ... the number of people who come forward to donate organs especially ... to undergo kidney transplants has widened to more than four years. ...
... Chief of the Specialty Hospital in the United States, ... a shot in the arm.//Specialty Hospitals thought of as ... was nipped in the bud, owing to vested interests ... The Wall Street Journal, has expressed disappointment at the ...
... can be detected years before the symptoms even appear, according ... the size of two parts of the brain, according to ... Those with a smaller hippocampus or amygdala are much more ... General Psychiatry. ,Both parts decline in size ...
... Alarming reports of AIDS patients being robbed off their pockets ... shift in the service based health care system, // believed ... ,Cai had no AIDS related symptoms when she was admitted ... she had, ensured prompt medical attention at the time of ...
... A considerable improvement in the oral feeding habits of ... 11 days following institution of feeding facilitating techniques. // ... been the use of a feeding tube. Prolonged use ... risk for development of gastroesophageal reflux. With the introduction ...
Cached Medicine News:Health News:Russia warns against travel to Turkey, Iran closes border 2Health News:AIDS Patients Deceived By Private Health Care System In China 2Health News:New Technique Enables Better Nursing Of Robin Sequence Infants 2
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "D-dimer Testing Market - ... and Forecast 2014 - 2022" report to ... in vitro diagnostics market is one of the ... be attributed to the improved health care awareness, ...
(Date:7/27/2015)... , July 17, 2015 Research and ... of the "G-Protein Coupled Receptors Market: Global ... 2014 - 2022" report to their offering. ... been segmented based on of assay type, therapeutic ... GPCRs market has been categorized into six major ...
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology ... announces a strategic cooperation with the South Korean BioTech ... a joint venture Medybloom to develop and promote Type ... China . Medytox, the Botulinum ... and is also the fourth company in the world ...
Breaking Medicine Technology:D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3
Rapid assay, results in 1 hours,Assay sensitivity of 1.14 ng/mL...
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
... digital x-ray detectors from KUBTEC represents a ... 12 to 16 bit digital interface. The ... array sensor with pixel spacing down to ... low x-ray energies (10-50 kV) and an ...
... from KUBTEC is a dual capability system with ... representation of the specimen under test. While the ... images, the micro focus source also allows the ... standard 2D images. The 100 mm x 100 ...
Medicine Products: